Jaguarhealth.gcs-web.com
Investor Overview Jaguar Health, Inc.
WEBAbout the Jaguar Health Family of Companies. Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, …
Actived: 3 days ago
Press Releases Jaguar Health, Inc.
WEB03/27/24. Jaguar Health to Hold Investor Webcast Monday, April 1st at 8:30 AM Eastern Regarding Q4 2023 Financials & Corporate Updates. 03/20/24. GEN to Commercialize Jaguar Health's Crofelemer in Turkey and Eight Neighboring Countries and Invest $2 Million in Jaguar Stock at 75% Premium to Market. 02/23/24.
Jaguar Health Announces Topline Results of Investigator-Initiated …
WEBCrofelemer is a novel, oral plant-based non-opioid antidiarrheal medication. SAN FRANCISCO, CA / ACCESSWIRE / November 19, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced topline results of the third-party, investigator-initiated Phase 2 HALT-D trial evaluating crofelemer for the prevention of chemotherapy-induced …
News Release Details
WEBPrimary endpoint based on patient reported outcomes from study expected in October 2023. With the completion of the PIPE financing of unregistered shares and 6-month lock up term, Jaguar has agreed, as described below, not to issue additional equity securities before October 22, 2023 - by which point the Company expects to have …
FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for
WEBCanalevia ®-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDA. Crofelemer, Jaguar's novel, oral plant-based drug sustainably harvested from the Croton lechleri tree, is the active ingredient in Canalevia-CA1
Jaguar Health, Inc.
WEBEstimated annual US revenue for Takeda’s SBS drug Gattex: ~$555 million. Global SBS market projected to reach $4.6 billion by 2027 with a CAGR of 26% from 2020 to 20275 (doesn’t include potential contribution from crofelemer’s novel mechanism of action) American Cancer Society. Cancer Facts & Figures 2023.
Jaguar Animal Health to Host Treatment Forum for Veterinarians …
WEBCanalevia ™-CA1, which received conditional approval from the FDA on December 21, 2021, is the first and only treatment for CID in dogs to receive any type of approval from the FDA. U.S. veterinarians, veterinary oncologists, and members of the media can click here to register for the CID Treatment Forum SAN FRANCISCO, CA / …
News Release Details
WEBCost of Product Revenue: Total cost of product revenue for the quarter ended September 30, 2022 was the same amount at $0.6 million for the quarter ended September 30, 2021. Research and Development: The R&D expense increased by $2.6 million, from $3.3 million for the quarter ended September 30, 2021 to $5.9 million during …
Napo Pharmaceuticals, a Jaguar Health Family Company, Accepted …
WEBTop line results of this pivotal trial expected before Thanksgiving. More than 1 million cancer patients in the US receive chemotherapy or radiation each year, according to the CDC, and cancer patients with diarrhea are 40% more likely to discontinue their targeted therapy
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit …
WEBJaguar planning to begin commercial launch of FDA-approved Gelclair ® prescription gel for oral mucositis (also called "chemo mouth") in Q3 2024. Company to feature "Make Cancer Less Shitty" patient advocacy program at ONS CongressSAN FRANCISCO, CA / ACCESSWIRE / April 22, 2024 / Jaguar Health, Inc. …
Historical Price Lookup Jaguar Health, Inc.
WEBMay 7, 2024. $0.30. 44,179,699. 1:1. $0.29. $0.30. $0.27. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the
News Release Details
WEBJaguar planning for launch of Canalevia ™ for CID in dogs this December. Canalevia is the first and only oral plant-based prescription drug candidate for CID in dogs. SAN FRANCISCO, CA / ACCESSWIRE / September 23, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that it was informed on September 21, 2021 by the …
Magdalena Biosciences, a Joint Venture between Jaguar Health …
WEBMagdalena Biosciences, a joint venture recently formed by Jaguar Health and Filament Health Corp., is focused on developing novel, natural prescription medicines derived from plants for mental health indications. SAN FRANCISCO, CA / ACCESSWIRE / October 30, 2023 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that …
Jaguar Health Announces Submission of Orphan Drug Designation
WEBCholera is an acute diarrheal illness caused by infection of the intestine with the bacterium Vibrio cholerae. Crofelemer previously granted Orphan Drug Designation by the FDA and the EMA for both short bowel syndrome and microvillus inclusion disease
Jaguar Health Announces FDA Activation of Third-Party …
WEBNapo Pharmaceuticals, a Jaguar Health company and the manufacturer of crofelemer, is supporting this physician-generated IND. SAN FRANCISCO, CA / ACCESSWIRE / August 1, 2023 / Jaguar Health (NASDAQ:JAGX) ("the Company") today announced the activation by the U.S. Food and Drug Administration (FDA) of a …
Jaguar Health Provides Corporate Update and Outlines 2022 …
WEB2021 was a year of progress for Jaguar Health as the company advanced its key human pipeline initiatives focused on chemotherapy-related diarrhea (CTD) and short bowel syndrome with intestinal failure (SBS-IF) and received conditional approval for Canalevia™-CA1 (crofelemer) for dogs. Pipeline advancing in 2022 with company's …
Jaguar Health Enters Exclusive Crofelemer Revenue Sharing …
WEBQuadri Pharma will cover 50% of the costs of development activity up to a capped dollar contribution. Jaguar to host virtual educational webinar on intestinal failure with leading gastroenterologists and nutrition experts November 8 th from 1:00 PM to 2:30 PM EST; Click here to register for the webinar. SAN FRANCISCO, CA / ACCESSWIRE / …
Top Categories
Popular Searched
› Cameroon health care for expats
› Atrium health huntersville nc phone number
› Philhealth vice president cabrieto
› Is eating sunflower seeds healthy
› Ladies first health care flint
› Marshall pickens mental health
Recently Searched
› Benefits of humor in mental health
› Aetna better health member services phone number
› Vibra health plan phone number
› Importance of urban planning for health
› Caretalk health care coverage
› Ramsay health care market share
› Singhealth digital medical certificate check
› Psychiatric mental health nursing notes
› Infirmary occupational health hours